Maximising the impact of patient reported outcome assessment for patients and society
dc.contributor.author | Calvert, M | |
dc.contributor.author | Kyte, D | |
dc.contributor.author | Price, G | |
dc.contributor.author | Valderas, JM | |
dc.contributor.author | Hjollund, NH | |
dc.date.accessioned | 2019-02-15T12:37:22Z | |
dc.date.issued | 2019-01-24 | |
dc.description.abstract | Over the past decade we have seen a global rise in the involvement of patients in coproducing research and decisions about their health and care. “Measuring what matters to patients” is recognised as central to improving patient care and service delivery, but patients need to be involved in deciding what to measure and how.1 One way to measure what matters is using patient reported outcome measures (PROMs), which are questionnaires completed by patients to assess the effects of disease or treatment (or both) on symptoms, functioning, and health related quality of life from their perspective. PROM data can be used to inform health technology assessment, pharmaceutical labelling claims, health policy and service improvement, and can support communication between patients and healthcare professionals.23 Here we discuss the current applications and potential benefits of PROMs in healthcare and challenges that reduce their potential to drive improvements in patient care. We focus on recent developments in the use of PROMs and consider strategies for efficient PROM data collection to maximise benefits for patients and society. | en_GB |
dc.description.sponsorship | National Institute for Health Research (NIHR) | en_GB |
dc.identifier.citation | Vol. 364, article k5267 | en_GB |
dc.identifier.doi | 10.1136/bmj.k5267 | |
dc.identifier.uri | http://hdl.handle.net/10871/35944 | |
dc.language.iso | en | en_GB |
dc.publisher | BMJ Publishing Group | en_GB |
dc.relation.url | https://www.ncbi.nlm.nih.gov/pubmed/30679170 | en_GB |
dc.rights | © Authors 2018. Reuse of this version (excluding any databases, tables, diagrams, photographs and other images or illustrative material included where a another copyright owner is identified) is permitted strictly pursuant to the terms of the Creative Commons Attribution-Non Commercial 4.0 International (CC-BY-NC 4.0) http://creativecommons.org | en_GB |
dc.title | Maximising the impact of patient reported outcome assessment for patients and society | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2019-02-15T12:37:22Z | |
exeter.place-of-publication | England | en_GB |
dc.description | This is the final version. Available on open access from BMJ Publishing Group via the DOI in this record | en_GB |
dc.identifier.journal | BMJ | en_GB |
dc.rights.uri | https://creativecommons.org/licenses/by-nc/4.0/ | en_GB |
dcterms.dateAccepted | 2018-12-03 | |
rioxxterms.version | VoR | en_GB |
rioxxterms.licenseref.startdate | 2018-12-03 | |
rioxxterms.type | Journal Article/Review | en_GB |
refterms.dateFCD | 2019-02-12T09:25:49Z | |
refterms.versionFCD | VoR | |
refterms.dateFOA | 2019-02-15T12:37:26Z | |
refterms.panel | A | en_GB |
refterms.depositException | publishedGoldOA |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's licence is described as © Authors 2018. Reuse of this version (excluding any databases,
tables, diagrams, photographs and other images or illustrative material
included where a another copyright owner is identified) is permitted
strictly pursuant to the terms of the Creative Commons Attribution-Non
Commercial 4.0 International (CC-BY-NC 4.0) http://creativecommons.org